Renovis
South San Francisco, California, United States
About Renovis
Renovis, Inc. is a biopharmaceutical company developing drugs to treat neurological diseases and disorders. The Company is currently developing products for acute ischemic stroke, for the treatment of neuropathic pain, and for the treatment of acute post-operative pain.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Delisted
- Employees: 51 – 100
- Estimated revenue: $1K – $10K
- Total funding: $84.2M
- Funding stage: M&A
- Last round: Post-IPO Equity (Aug 2016)
- Ticker: nasdaq:RNVS
- Website: renovis.com
- Phone: (909)557-2360
Industries & Categories
Innovation Management, Medical, Professional Services
Social Profiles
Canonical: https://fsome.com/organization/renovis-2204555 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.